International [Chinese COVID Vaccines News] After Sowing Propaganda Against mRNA Tech, China Realize They Needs It

Best vaccine, does not have adverse reactions like JJ, Moderna or Pfizer. They are all shit vaccines at least this is "safer"
 
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the Omicron variant, said Hong Kong researchers in initial lab findings.

 
Last edited:
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the Omicron variant, said Hong Kong researchers in initial lab findings.




Another vaccine being smeared by the media. Isn't it funny how the ONLY vaccine that has had zero negative coverage, is Pfizer who conveniently sponsor 90% of America media / news channels?

Biggest scam in the history of mankind.
 
Another vaccine being smeared by the media. Isn't it funny how the ONLY vaccine that has had zero negative coverage, is Pfizer who conveniently sponsor 90% of America media / news channels?

Biggest scam in the history of mankind.

You guys one minute are talking shit about China and their shitty manufacturing but when it comes to their vaccine, you think they somehow make things differently?

Don’t worry poster, mRNA technology will save yours or someone you love life down the road. When mRNA technology will prevent you from getting cancer will you shun it?
 
You guys one minute are talking shit about China and their shitty manufacturing but when it comes to their vaccine, you think they somehow make things differently?

Don’t worry poster, mRNA technology will save yours or someone you love life down the road. When mRNA technology will prevent you from getting cancer will you shun it?


When something finally works will you shun it? lol

As for talking shit about China, Covid was financially supported by the US, lab leak was a joint venture by both sides.
 
When something finally works will you shun it? lol

As for talking shit about China, Covid was financially supported by the US, lab leak was a joint venture by both sides.

COVID was financially supported by the Trump administration? I’m not even going to make that level of 6 degrees of separation. You make it sound like the US caused COVID. Accidents happen. But how is that a response to China having shit tier manufacturing and your support for their vaccine?

It’s amazing how COVID has caused so many of you to abandon positions you hold so dearly.
 
COVID was financially supported by the Trump administration? I’m not even going to make that level of 6 degrees of separation. You make it sound like the US caused COVID. Accidents happen. But how is that a response to China having shit tier manufacturing and your support for their vaccine?

It’s amazing how COVID has caused so many of you to abandon positions you hold so dearly.

Not supporting any vaccine, just stating the obvious, Sinopharm has the least side effects. And Covid was supported by NIH funding of a lab in China, to circumvent laws for safety. So no contradiction saying most vaccines suck and telling US is just as responsible for this disaster.
 
Not supporting any vaccine, just stating the obvious, Sinopharm has the least side effects. And Covid was supported by NIH funding of a lab in China, to circumvent laws for safety. So no contradiction saying most vaccines suck and telling US is just as responsible for this disaster.

That’s like saying Africa is responsible for Ebola. At this point, there is 0 evidence COVID was man made. I don’t want to rehash RNA similarities because they aren’t even close.
 
When something finally works will you shun it? lol

As for talking shit about China, Covid was financially supported by the US, lab leak was a joint venture by both sides.

The vaccines are working. We’ve provided data that shows the unvaccinated are dying at a unfathomable rate compared to the vaccinated. I’m not sure what more could convince you.
 
2 doses of Sinopharm vaccine offers very weak protection against Omicron
Zhuang Pinghui | 18 Dec 2021

1411336.jpg

The Omicron variant of the coronavirus evades immunity offered by an inactivated Covid-19 vaccine developed by Sinopharm, a lab study has found.

Researchers from the University of Washington and Swiss antibody therapeutics company Humabs BioMed investigated how the Omicron variant might escape immunity from past infections or vaccination by comparing the performance of plasma from recovered Covid-19 patients and people vaccinated with six major Covid-19 vaccines.

They tested how the plasma worked against a pseudovirus genetically modified to resemble the ancestral and Omicron variants of the virus that causes Covid-19. The results of the study, which were not peer-reviewed, were published on BioRxiv.org.

Results showed the antibody levels of people vaccinated with Sinopharm’s vaccine dropped significantly against Omicron compared with the ancestral, or older, strain and, of the total 13 participants, only three people could be found to produce detectable antibodies that could block the Omicron strain of the virus from entering cells, a process known as “neutralising”.

David Veesler, associate professor at the department of biochemistry at the University of Washington and one of the correspondence authors of the study, said the in vitro studies evaluated plasma neutralising antibodies “which is a correlate of protection against Sars-CoV-2”, the virus that causes Covid-19.

“However, other factors such as T cells [an immune system cell] can play important roles to protect us against pathogens, especially in the absence of neutralising antibodies,” Veesler said.

“It is accurate to say that we could not detect plasma neutralising activity against Omicron in most Sinopharm vaccines. Evaluating vaccine-efficacy in the human population will require epidemiology studies.”

A drop in effectiveness against Omicron was observed in all six vaccines tested, but participants vaccinated with Moderna, Pfizer and AstraZeneca vaccines displayed higher levels of neutralising antibodies against the ancestral strain and, after a 33-44-fold drop they still had detectable neutralising antibodies against the Omicron variant.

The study follows a similar one conducted by the University of Hong Kong, which showed that two doses of Sinovac, the Covid-19 vaccine most used in the world, could not prevent infection from the Omicron variant. It also offered a rare glimpse into the effectiveness of vaccines widely used in low-income countries but less studied than mRNA vaccines.

https://www.thestar.com.my/aseanplu...eak-protection-against-new-strain-finds-study

"Evaluating vaccine-efficacy in the human population will require epidemiology studies"

The important part. I would suggest that 'almost no protection against Omicron' should be unlikely, but lets see.
 
The vaccines are working. We’ve provided data that shows the unvaccinated are dying at a unfathomable rate compared to the vaccinated. I’m not sure what more could convince you.

Short window of effectiveness and constant boosters. Yes its working
 
"Evaluating vaccine-efficacy in the human population will require epidemiology studies"

The important part. I would suggest that 'almost no protection against Omicron' should be unlikely, but lets see.

Unfortunately most of the countries that use Chinese vaccines are also the least likely to be able to keep detailed statistic of its efficacy, but we should get a pretty clear picture by looking at the hospitalization rate around the world after this holidays season.

The good news is, fast-spreading Omicron is also milder than Delta in most of the recorded cases thus far.
 
Last edited:
China's Sinovac booster shot is 94% efficient against Omicron, claims company
ANI | Dec 17, 2021

88331499.jpg

BEIJING: China's biotech firm Sinovac claimed that a third dose of its Covid-19 vaccine is 94 per cent effective against the Omicron variant of the Covid-19.

This comes a day after a study found that the two doses of the vaccine failed to generate any detectable antibody response against the fast-spreading variant.

The study was conducted by the company on 20 people who received two shots and another 48 who received three shots. Seven in the first group and 45 in the second tested positive in neutralizing antibodies against the Omicron variant, the company said in a statement to the Global Times.

Sinovac said that the data demonstrated that the administration of a booster shot of its vaccine can effectively enhance the vaccine's neutralizing capacity to the Omicron variant, read the statement.

The company's findings are in contrast with those released on Tuesday in a preprint paper by the HKU researchers.

The university study also examined neutralising antibodies, one arm of immune response that serves as a rough marker for protection against infection.

Of 25 people who received a full two-dose course of CoronaVac, none were found to have detectable levels of neutralising antibodies, according to study author and top infectious disease expert Yuen Kwok-yung and his team.

The Omicron variant, first discovered in early November, has been reported in 77 countries and regions, according to the World Health Organization.

https://timesofindia.indiatimes.com...icron-claims-company/articleshow/88331501.cms
 
Three Sinovac Doses Fail to Protect Against Omicron in Hong Kong Lab Study
By Jinshan Hong | December 23, 2021

2HTBHR7VRBLBHNFKUQ4YZT46UI.jpg

Two doses and a booster of the Covid-19 vaccine made by China’s Sinovac Biotech Ltd., one of the most widely used in the world, didn’t produce sufficient levels of neutralizing antibodies to protect against the omicron variant, a laboratory study found.

The research suggests that people who’ve received Sinovac’s shot, known as CoronaVac, should seek out a different vaccine for their booster: Getting Germany’s BioNTech SE’s messenger RNA as a third dose saw those previously fully vaccinated with CoronaVac significantly improve in protective levels of antibodies against omicron, according to the study from the University of Hong Kong and The Chinese University of Hong Kong.

Two doses of the BioNTech shot, known as Comirnaty, was also insufficient, though adding a booster of the same type raised protection to adequate levels, the researchers said in a statement.

While much is still unknown about how Sinovac’s shot holds up to omicron -- including how T cells, the immune system’s weapon against virus-infected cells, will respond -- the initial results are a blow to those who have received CoronaVac. There have been more than 2.3 billion doses of the shot produced and shipped out, mostly in China and the developing world.

With omicron seen to be about 70 times more transmissible than the delta variant, the prospect of having to roll out different boosters or even re-vaccinate with a more omicron-specific vaccine will set back the world’s efforts to exit the pandemic.

Last week, Sinovac released lab studies saying 94% of people getting three doses generated neutralizing antibodies, though it didn’t say what level. The Hong Kong researchers set a threshold for what they considered a sufficient level of antibodies for protection based on earlier studies published in the journal Nature Medicine.

Sinovac representatives didn’t immediately respond to calls seeking comment.

The research, led by Malik Peiris and David Hui, examined the production of virus neutralizing antibodies in the blood of people vaccinated with the two shots currently in use in Hong Kong. They confirm two doses of either vaccine wasn’t sufficient to fend off omicron.

The news comes as Hong Kong’s medical advisers cleared the way for adults in the city to receive a booster shot, no matter which vaccine they initially received. The new study suggests there are critical differences between them.

The findings are bad news for China, which has managed to insulate the vast majority of its people from Covid-19 with closed borders and strict containment measures, but now faces the challenge of keeping omicron out. The government has given out 2.6 billion homegrown shots -- many of them CoronaVac -- to its population of 1.4 billion people, but will likely have to develop and roll out new vaccines before it can shift away from its isolationist stance.

https://www.bloomberg.com/news/arti...s-fail-to-protect-against-omicron-study-shows
 
Last edited:
Another vaccine being smeared by the media. Isn't it funny how the ONLY vaccine that has had zero negative coverage, is Pfizer who conveniently sponsor 90% of America media / news channels?

Biggest scam in the history of mankind.

Your original source of anti-mRNA propaganda is already back-pedaling. Time to catch up with your CCP commissars.

https://forums.sherdog.com/posts/165655767/
 
Back
Top